About Eiko Lifesciences Ltd
Eiko Lifesciences engaged in specialty chemicals and pharmaceutical intermediates sector, the Company is committed to conducting its business with the highest standards of integrity, ethical conduct, transparency and accountability. The governance framework of the Company is designed to ensure responsible decision-making, effective risk management, regulatory compliance and protection of stakeholder interests while fostering innovation, operational excellence and business sustainability.
Founded
1977
CEO
Laxmikant Kabra
Employees
7
HQ
Thane, Maharashtra
Finished Products
1Sale of Products
₹60.42CrRaw Materials
1Cost of Materials Consumed
₹57.03CrAbout Eiko Lifesciences Ltd
Eiko Lifesciences engaged in specialty chemicals and pharmaceutical intermediates sector, the Company is committed to conducting its business with the highest standards of integrity, ethical conduct, transparency and accountability. The governance framework of the Company is designed to ensure responsible decision-making, effective risk management, regulatory compliance and protection of stakeholder interests while fostering innovation, operational excellence and business sustainability.
Founded:1977
CEO:Laxmikant Kabra
Employees:7
HQ:Thane, Maharashtra
Finished Products
1Sale of Products
₹60.42CrRaw Materials
1Cost of Materials Consumed
₹57.03CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹64
52W Low
₹45
Volume12.43K
Avg VolumeN/A
Beta0.49
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
11.87x
Valuation
P/B Ratio
1.02x
Valuation
EPS
₹3.90
Valuation
Dividend Yield
0.00%
Valuation
ROE
6.54%
Profitability
ROCE
10.13%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.07x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
71.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.